WOBURN, Mass.--(BUSINESS WIRE)--Abpro, an integrated life science company at the forefront of synthetic biology, today announced a partnership with Essex Bio, a China-based biopharmaceutical company.
![]()
↧
Abpro Announces Investment and Partnership with Essex Bio for Development of Antibody Therapeutics
↧